Aptamers Engineered Nanocarriers for Cancer Therapy
eBook - ePub

Aptamers Engineered Nanocarriers for Cancer Therapy

  1. 556 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Aptamers Engineered Nanocarriers for Cancer Therapy

About this book

Aptamers Engineered Nanocarriers for Cancer Therapy details the selection technologies, biological characteristics, and clinical uses of aptamer-based nano agents for cancer therapeutics. The book helps facilitate speedy solutions for some of the problems pertaining to the manufacture of nano-aptamers – such as toxicity, thermal stability, cost efficiency, tumor penetration and blood stability. Key chapters cover cell-SELEX technology for aptamer selection, mechanisms of multi-drug resistance of cancer, the relevance of aptamers as anticancer therapies, as well as the broad range of aptamer-functionalized nanostructures available. This book provides exciting insights into this relatively new approach to cancer therapeutics, and will be of interest to materials scientists, biomedical engineers, molecular biologists, biochemists and clinical scientists, with a focus on cancer therapy. - Reviews the mechanisms behind multi-drug resistance (MDR) in cancer and how aptamer-mediated novel therapeutic agents and strategies can facilitate MDR reversal - Covers a range of aptamers engineered nanostructures, including PLGA nanoparticles, silica nanoparticles, quantum dots, nucleic acid aptamers, and more - Discusses the challenges associated with using aptamers as cancer therapeutics and how this translates into clinical use

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Aptamers Engineered Nanocarriers for Cancer Therapy by Prashant Kesharwani in PDF and/or ePUB format, as well as other popular books in Tecnologia e ingegneria & Biotecnologia in medicina. We have over one million books available in our catalogue for you to explore.

Table of contents

  1. Title of Book
  2. Cover image
  3. Title page
  4. Table of Contents
  5. Copyright
  6. Contributors
  7. 1 Cell-SELEX technology for aptamer selection
  8. 2 Aptamers in biosensing: biological characteristics and applications
  9. 3 Mechanisms of multidrug resistance in cancer
  10. 4 Relevance of aptamers as targeting ligands for anticancer therapies
  11. 5 Aptamers as smart ligands for the development of cancer-targeting nanocarriers
  12. 6 Aptamer-functionalized liposomes for targeted cancer therapy
  13. 7 Aptamer-functionalized micelles for targeted cancer therapy
  14. 8 Aptamer-functionalized nanoparticles for targeted cancer therapy
  15. 9 Aptamer-functionalized PLGA nanoparticles for targeted cancer therapy
  16. 10 Aptamer-functionalized silicon nanoparticles for targeted cancer therapy
  17. 11 Aptamer-functionalized dendrimers for targeted cancer therapy
  18. 12 Aptamer-conjugated carbon nanotubes or graphene for targeted cancer therapy and diagnosis
  19. 13 Aptamer-functionalized quantum dots for targeted cancer therapy
  20. 14 Cancer immunotherapy via nucleic acid aptamers
  21. 15 Recent advances in aptamer-based nanomaterials in imaging and diagnostics of cancer
  22. 16 Microdevice-based aptamer sensors
  23. 17 Aptamer-based microfluidics for circulating tumor cells
  24. 18 Aptamer-based theranostic approaches for treatment of cancer
  25. 19 Challenges of aptamers as targeting ligands for anticancer therapies
  26. 20 Clinical use and future perspective of aptamers
  27. Index